Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack Acquires 1,500 Shares

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack acquired 1,500 shares of the company’s stock in a transaction on Monday, February 24th. The stock was bought at an average cost of $15.92 per share, with a total value of $23,880.00. Following the completion of the acquisition, the director now directly owns 60,583 shares in the company, valued at approximately $964,481.36. This represents a 2.54 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Catherine Cusack also recently made the following trade(s):

• On Friday, February 21st, Catherine Cusack acquired 1,000 shares of Sabra Health Care REIT stock. The stock was bought at an average cost of $16.43 per share, with a total value of $16,430.00.

Sabra Health Care REIT Trading Up 3.4 %

Shares of SBRA stock opened at $16.42 on Wednesday. The firm has a market capitalization of $3.91 billion, a P/E ratio of 30.98, a P/E/G ratio of 1.97 and a beta of 1.25. Sabra Health Care REIT, Inc. has a twelve month low of $13.31 and a twelve month high of $20.03. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88. The stock’s fifty day simple moving average is $16.79 and its 200 day simple moving average is $17.63.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, hitting the consensus estimate of $0.36. The firm had revenue of $182.35 million for the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. As a group, sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 7.31%. The ex-dividend date of this dividend is Friday, February 14th. Sabra Health Care REIT’s payout ratio is presently 226.42%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research note on Tuesday, January 7th. Truist Financial lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price target for the company from $18.00 to $17.00 in a research note on Friday, January 17th. Finally, Mizuho restated a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Three analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $18.86.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Mackenzie Financial Corp lifted its holdings in Sabra Health Care REIT by 22.1% during the 4th quarter. Mackenzie Financial Corp now owns 289,870 shares of the real estate investment trust’s stock worth $5,021,000 after buying an additional 52,441 shares during the period. GF Fund Management CO. LTD. acquired a new position in Sabra Health Care REIT during the 4th quarter worth about $74,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Sabra Health Care REIT by 2.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,444,703 shares of the real estate investment trust’s stock valued at $25,022,000 after purchasing an additional 40,127 shares during the period. Two Sigma Advisers LP lifted its stake in shares of Sabra Health Care REIT by 21.3% in the 4th quarter. Two Sigma Advisers LP now owns 182,500 shares of the real estate investment trust’s stock valued at $3,161,000 after purchasing an additional 32,100 shares during the period. Finally, Systematic Financial Management LP lifted its stake in shares of Sabra Health Care REIT by 4.3% in the 4th quarter. Systematic Financial Management LP now owns 2,391,104 shares of the real estate investment trust’s stock valued at $41,414,000 after purchasing an additional 98,631 shares during the period. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.